Expression and purification of a recombinant buforin derivative from Escherichia coli

Process Biochemistry

Volumn 39, Issue 11, 2004, Pages 1731-1736

  Pyo, Sang Hyun ^a   Lee, Jae Hyun ^a   Park, Heung Bok ^a   Cho, Jin Suk ^a   Kim, Hong Rak ^a   Han, Byung Hee ^b   Park, Yeon Sung ^a  

^a Samyang Corporation   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

Antimicrobial peptide; Buforin IIb; Chemical cleavage; Expression and purification; Fusion protein

Indexed keywords

CATIONIC POLYMERIZATION; CELLS; CULTIVATION; DNA; ESCHERICHIA COLI; PROTEINS;

FUSION PROTEINS; MOLECULAR MASSES;

BIOCHEMISTRY;

ESCHERICHIA COLI;

EID: 3042850735     PISSN: 00329592     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.procbio.2003.07.007     Document Type: Article

References (23)

1. Iijima R., Kisugi J., Yamazaki Y. A novel antimicrobial peptide from the sea hare Dolabella auricularia. Dev. Comp. Immunol. 27:2003;305-311
2. Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. U.S.A. 84:1987;5449-5453
3. Hara S., Yamakawa M. Moricin, a novel type of antibacterial peptide isolated from the silkworm, Bombyx mori. J. Biol. Chem. 70:1995;29923-29927
4. Park C.B., Kim M.S., Kim S.C. A novel antimicrobial peptide from Bufo bufo gargarizans. Biochem. Biophys. Res. Commun. 218:1996;408-413
5. Nicolas P., Mor A. Peptides as weapons against microorganisms in the chemical defense system of vertebrates. Annu. Rev. Microbiol. 49:1995;277-304
6. Fuchs P.C., Barry A.L., Brown S.D. In vitro antimicrobial activity of MSI-78, a Magainin analog. Antimicrob. Agents Chemother. 42:1998;1213-1216
7. Merrifield R.B. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 85:1963;2149-2154
8. Harrison SJ, McManus AM, Marcus JP, Goulter KC, Green JL, Nielsen KJ, et al. Purification and characterization of a plant antimicrobial peptide expression in Eschericha coli 1999;15:171-7.
9. Zhang L., Falla T., Wu M., Fidai S., Burian J., Kay W., et al. Determinants of recombinant production of antimicrobial cationic peptides and creation of peptide variant in bacteria. Biochem. Biophys. Res. Commun. Protein Express. Purif. 247:1998;674-680
10. Lee J.H., Kim J.H., Hwang S.W., Lee W.J., Yoon H.K., Lee H.S., et al. High level expression of antimicrobial peptide mediated by a fusion partner reinforcing formation of inclusion bodies. Biochem. Biophys. Res. Commun. 277:2000;575-580
11. Hwang S.W., Lee J.H., Park H.B., Pyo S.H., So J.E., Lee H.S., et al. A simple method for the purification of an antimicrobial peptide in recombinant Escherichia coli. Mol. Biotechnol. 18:2001;193-198
12. Park C.B., Kim H.S., Kim S.C. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem. Biophys. Res. Commun. 244:1998;253-257
13. Park C.B., Yi K.S., Matsuzaki K., Kim M.S., Kim S.C. Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. Proc. Natl. Acad. Sci. U.S.A. 97:2000;8245-8250
14. Sandgathe A., Tippe D., Dilsen S., Meens J., Halfar M., Weuster-Botz D., et al. Production of a human calcitonin precursor with Staphylococcus carnosus: secretory expression and single-step recovery by expanded bed dasorption. Process Biochem. 38:2003;1351-1363
15. Gavit P., Better M. Production of antifungal recombinant peptides in Escherichia coli. J. Biotechnol. 79:2000;127-136
16. Tso J.Y., Zalkin H., van Cleemput M., Yanofsky C., Smith J.M. Nucleotide sequence of Escherichia coli purF and deduced amino acid sequence of glutamine phosphoribosylpyrophosphate amidotransferase. J. Biol. Chem. 257:1982;3525-3531
17. Ausubel FM, Brent R, Kingstone RE, Moore DD, Seidman JG, Smith JA, et al. Current protocols in molecular biology. New York: Wiley; 1995.
18. Park H.B., Pyo S.H., Hong S.S., Kim J.H. Optimization of the hydroxylamine cleavage of an expressed fusion protein to produce a recombinant antimicrobial peptide. Biotechnol. Lett. 23:2001;637-641
19. Loh K.C., Yao Z.J., Yap M.G.S., Chung M.C.M. Role of polyethyleneimine in the purification of recombinant human tumour necrosis factor beta. J. Chromatogr. A. 760:1997;165-171
20. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685
21. Fletcher J.R., Ramwell P.W. The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs. Circ. Shock. 7:1980;299-308
22. Fraker D.L., Stovroff M.C., Merino M.J., Norton J.A. Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity. J. Exp. Med. 168:1988;95-105
23. Anspach F.B. Endotoxin removal by affinity sorbents. J. Biochem. Biophys. Methods. 49:2001;665-681